<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01350687</url>
  </required_header>
  <id_info>
    <org_study_id>farid.CTIL</org_study_id>
    <nct_id>NCT01350687</nct_id>
  </id_info>
  <brief_title>Pulmonary Hypertension Prevention in Hemodialysis</brief_title>
  <official_title>New Phosphore Binders in Prevention of Pulmonary Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Baruch Padeh Medical Center, Poriya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Baruch Padeh Medical Center, Poriya</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pulmonary hypertension is a new complication described in hemodialysis patients. in the last
      year these patients were treated by calcium carbonate orally to control serum phosphor.
      Calcium phosphor deposits in pulmonary artery can explain this phenomena. The investigators
      want to investigate the new phosphor non calcium containing agents in hemodialysis patients
      and to measure the pulmonary pressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will measure pulmonary blood pressure before and after treatment with new
      phosphor binders, non calcium containing.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>June 2011</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        40 patients on hemodialysis treated with Phosphore biders, non-calcium containig.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hemodialysis Patients without fistula

        Exclusion Criteria:

          -  Heart Disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Farid Nakhoul, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Poria medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Poria Medical Center</name>
      <address>
        <city>Tiberias</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Farid Nakhoul, Prof</last_name>
      <phone>97246652587</phone>
      <email>fnakhoul@poria.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Farid Nakhoul, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2011</study_first_submitted>
  <study_first_submitted_qc>May 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2011</study_first_posted>
  <last_update_submitted>May 9, 2011</last_update_submitted>
  <last_update_submitted_qc>May 9, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2011</last_update_posted>
  <responsible_party>
    <name_title>Avi On</name_title>
    <organization>Poria Medical Center</organization>
  </responsible_party>
  <keyword>Calcium Phosphore</keyword>
  <keyword>Renagel</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

